Reading Time: 1 minute
In the tender offer, DNA’s shareholders are offered a cash consideration of EUR 20.90 for each share. The offer price represents a premium of 7.4% compared to the closing share price on 8 April 2019 and a 21.3% premium compared to the three-month volume weighted average share price preceding 9 April 2019 (adjusted for dividend**).
The Board of Directors of DNA, acting through its independent members, unanimously recommends that the shareholders of DNA accept the tender offer.
More information can be found on the DNA Mandatory Tender Offer webpage.
*The offeror reserves the right to extend the offer period.
**DNA cash dividend of EUR 1.10 per share has been adjusted for 8 January 2019 – 28 March 2019.
For general questions for Telenor Investor Relations
Telenor Group Head of Investor Relations
+47 9923 04 60
Director, Financial Communications
+47 901 10 606